Elopiprazole

Elopiprazole can be used in study of neurological disease and SARS-CoV-2[1].

Product Specifications

CAS Number

[115464-77-2]

UNSPSC

12352005

Target

SARS-CoV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/elopiprazole.html

Solubility

10 mM in DMSO

Smiles

FC1=CC=C(C2=CC=C(CN3CCN(CC3)C4=CC=CC5=C4OC=C5)N2)C=C1

Molecular Formula

C23H22FN3O

Molecular Weight

375.44

References & Citations

[1]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[2]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[3]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2.